A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis

European Journal of Immunology

Volumn 28, Issue 1, 1998, Pages 290-295

  Michel, Jan ^a   Langstein, Joachim ^a   Hofstädter, Ferdinand ^a   Schwarz, Herbert ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cytokine receptor; Human; Inflammation; Rheumatoid arthritis

Indexed keywords

LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD137; ARTHRITIS, RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; POLYMERASE CHAIN REACTION; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA SPLICING; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0031974419     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199801)28:01<290::AID-IMMU290>3.0.CO;2-S     Document Type: Article

References (25)

1. Beutler, B. and van Huffel, C., Unraveling function in the TNF ligand and receptor families. Science 1994. 264: 667-668.
2. Smith, C. A., Farrah, T. and Goodwin, R. G., The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 1994. 76: 959-962.
3. Lotz, M., Setareh, M., von Kempis, J. and Schwarz, H., The nerve growth factor/tumor necrosis factor receptor family. J. Leucoc. Biol. 1996. 60: 1-7.
4. Kwon, B. S. and Weissman, S. M., cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 1989. 86: 1963-1967.
5. Schwarz, H., Tuckwell, J. and Lotz, M., A receptor induced by lymphocyte activation ILA: a new member of the human nerve growth factor/tumor necrosis factor receptor family. Gene 1993. 134: 295-298.
6. Alderson, M. R., Smith, C. A., Tough, T. W., Davis-Smith, T., Armitage, R. J., Falk, B., Roux, E., Baker, E., Sutherland, G. R., Din, W. S. and Goodwin, R. G., Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 1994. 24: 2219-2227.
7. Kishimoto, T., Goyert, S., Kikutani, H., Manson, D., Miyasaka, M., Moretta, L., Ohno, T., Okumura, K., Shaw, S., Spriner, T. A., Sagamura, K., Sugawara, H., von dem Borne, A. E. K. and Zola, H., Update of CD Antigens, 1996. J. Immunol. 1997. 158: 3035-3036.
8. Schwarz, H., Valbracht, J., Tuckwell, J., Kempis, J. and Lotz, M., ILA, the human 4-1BB homologue is inducible in lymphoid and other cell lines. Blood 1995. 85: 1043-1052.
9. Schwarz, H., Arden, K. and Lotz, M., CD137, a member of the tumor necrosis factor receptor family is located on chromosome 1 p36, in a cluster of related genes, and colocalized with several malignancies. Biochem. Biophys. Res. Commun. 1997. 235: 699-703.
10. Schwarz, H., Blanco, F., Valbracht, J., Kempis, J. and Lotz, M., ILA, A member of the human NGF/TNF receptor family regulates T lymphocyte proliferation and survival. Blood 1996. 87: 2839-2845.
11. Melero, I., Shuford W. W., Newby, S. A., Aruffo, A., Ledbetter, J. A., Hellström, K. E., Mittler, R. S. and Chen, L., Monoclonal antibodies agains 4-1BB T cell activation molecule eradicate established tumors. Nature Med. 1997. 3: 682-685.
12. Kohno, T., Brewer, M. T., Baker, S. L., Schwartz, P. E., King, M. W., Hale, K. K., Squires, C. H., Thompson, R. C. and Vannice, J. L., A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 1990. 87: 8331-8835.
13. Zupan, A. A., Osborne, P. A., Smith, C. E., Siegel, N. R., Leimgruber, R. M. and Johnson, E. M., Identification, purification, and characterization of truncated forms of the human nerve growth factor receptor. J. Biol. Chem. 1989. 20: 11714-11720.
14. Pizzolo, G., Vinante, F., Chilosi, M., Dallenbach, F., Josimovic-Alasevic, O., Diamantstein, T. and Stein, H., Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage. Br. J. Haematol. 1990. 75: 282-284.
15. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J. and Mountz, J. D., Protection from Fas mediated-apoptosis by a soluble form of the Fas molecule. Science 1994. 263: 1759-1762.
16. Cascino, I., Fiucci, G., Papoff, G. and Ruberti, G., Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 1995. 154: 2706-2713.
17. Cascino, I., Papoff, G., De-Maria, R., Testi, R. and Ruberti, G., Fas/Apo-1 CD95 receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol. 1996. 156: 13-17.
18. Bertini, R., Delgado, R., Faggioni, R., Gascon, M. P., Ythier, A. and Ghezzi, P., Urinary TNF-binding protein TNF soluble receptor protects mice against the lethal effect of TNF and endotoxic shock. Eur. cytokine Netw. 1993. 4: 39-42.
19. Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H. and Widmer, M. B., Soluble tumor necrosis factor TNF receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 1993. 151: 1548-1561.
20. Williams, R., Ghrayeb, J., Feldmann, M. and Maini, R., Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 1995. 84: 433-439.
21. Pizzolo, G., Vinante, F., Morosato, L., Nadali, G., Chilosi, M., Gandini, G., Sinicco, A., Raiteri, R., Semenzato, G., Stein, H. and Peronan, G., High serum level of the soluble form of CD30 molecule in the early phase of HIV infection as an independent predictor for progression to AIDS. AIDS 1994. 8: 741-745.
22. Zumkeller, W. and Schofield, P. N., Growth factors, cytokines and soluble forms of receptor molecules in cancer patients. Anticancer Res. 1995. 15: 343-348.
23. Aloe, L., Tuveri, M., Carcassi, U. and Levi-Montalcini, R., Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 1992. 35: 351-355.
24. Langstein, J., Hofstaedter, F. and Schwarz, H., Cis-9,10-octadecenoamide a sleep-inducing brain lipid inhibits lymphocyte proliferation. Res. Immunol. 1996. 147: 389-396.
25. Andreesen, R., Brugger, W., Scheibenbogen, C., Kreutz, M., Leser, H. G., Rehm, A. and Lohr, G. W., Surface phenotype analysis of human monocyte to macrophage maturation. J. Leukoc. Biol. 1990. 47: 490-497.